Dilemma of focal segmental glomerular sclerosis. 1996

L Cortes, and A Tejani
Department of Pediatrics, SUNY Health Science Center at Brooklyn, New York, USA.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D005923 Glomerulosclerosis, Focal Segmental A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE. Glomerulonephritis, Focal Sclerosing,Hyalinosis, Segmental Glomerular,Focal Segmental Glomerulosclerosis,Glomerulosclerosis, Focal,Hyalinosis, Segmental,Segmental Glomerular Hyalinosis,Focal Glomerulosclerosis,Focal Sclerosing Glomerulonephritides,Focal Sclerosing Glomerulonephritis,Glomerular Hyalinosis, Segmental,Glomerulonephritides, Focal Sclerosing,Sclerosing Glomerulonephritides, Focal,Sclerosing Glomerulonephritis, Focal,Segmental Glomerulosclerosis, Focal,Segmental Hyalinosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

L Cortes, and A Tejani
December 1985, Kidney international,
L Cortes, and A Tejani
October 2004, Nihon rinsho. Japanese journal of clinical medicine,
L Cortes, and A Tejani
December 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation,
L Cortes, and A Tejani
January 2013, Contributions to nephrology,
L Cortes, and A Tejani
June 1980, The American journal of medicine,
L Cortes, and A Tejani
May 2001, Clinical nephrology,
L Cortes, and A Tejani
June 2022, Kidney international reports,
L Cortes, and A Tejani
September 1986, Medicine,
L Cortes, and A Tejani
January 1998, Advances in nephrology from the Necker Hospital,
L Cortes, and A Tejani
March 1987, Nihon Jinzo Gakkai shi,
Copied contents to your clipboard!